Research
First-of-its-kind robotic cataract procedure makes debut at ASCRS
David F. Chang, MD, presents on ForSight Robotics’ first-of-its-kind hybrid intraocular robotic ophthalmic platform.
Business
ASCRS names Vance Thompson, MD, as president
Internationally-recognized specialist in laser vision correction and advanced cataract surgery will be inducted during the 2024 annual meeting.
Events
Canadian ophthalmologist receives 2024 ASCRS Foundation Chang-Crandall Humanitarian Award
Martin Spencer, MD, brings nearly 40 decades of humanitarian work.
Business
ASCRS names new executive director
Ophthalmic industry veteran Abigail Markward will lead the ASCRS Foundation.
Research
Orbis and FundamentalVR roll out VR cataract surgery training
Immersive simulation is designed exclusively to train surgeons in low- and middle-income countries.
Research
SAHARA crossover trial reports significant continued advantages of TearCare for DED
Additional 6-month data supports Sights Sciences’ tech vs Restasis as a primary treatment for addressing the underlying root cause of MGD.
Products
RxSight launches newest Light Adjustable Lens
The LAL+ marks the next installment of the first and only customizable IOL for cataract surgery.
Research
Keratoconus eye drop regenerates lost collagen in the eye
TheiaNova’s world-first therapy of its kind is featured during ASCRS’s Winning Pitch Challenge as part of the Eyecelerator conference.
Products
Johnson & Johnson unveils TECNIS Odyssey presbyopia-correcting IOL
Real-world data presented during ASCRS reports the IOL demonstrates a full range of continuous vision.
Research
Sight Sciences reports new data from GEMINI extension trial on OMNI Surgical System
Findings build on original 12-month results supporting its efficacy in lowering IOP and medication adherence in OAG.
Products
CSI Dry Eye Software releases new version of AI-based program
Latest version of the dry eye diagnostics and treatment software includes seven new features for remote-based disease management.
Pipeline
Oculis releases positive phase 3 data from OPTIMIZE-1 trial for post-op inflammation and pain
Announced at ASCRS, favorable results on once-daily, topical, and preservative-free topical formulation may support an eventual NDA submission.
Business
ASRS names new 2024-2025 president
Retinal specialist and vitreoretinal surgeon Reginald J. Sanders, MD, FASRS, has taken over leadership.
Products
ASRS reports safety concerns over Apellis' Syfovre
A reported six cases of retinal vasculitis have occurred in patients following the first intravitreal injection, the organization says.
Business